A Phase 1, Double-Blind, Randomized, Placebo-Controlled, Multi-Part, Single and Multiple Ascending Dose Study of CK-3773274 in Healthy Adult Subjects
Status: Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 15 Nov 2019
Price : $35 *
At a glance
- Drugs CK 274 (Primary)
- Indications Hypertrophic cardiomyopathy
- Focus Adverse reactions; First in man
- Sponsors Cytokinetics
- 11 Nov 2019 Planned number of patients changed from 108 to 120.
- 11 Nov 2019 Status changed from recruiting to active, no longer recruiting.
- 31 Oct 2019 According to a Cytokinetics media release, data were presented at the Heart Failure Society of Americas 23rd Annual Scientific Meeting in Philadelphia.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History